好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Mechanical Thrombectomy in patients with low NIHSS: A retrospective chart review
Cerebrovascular Disease and Interventional Neurology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
3-030

To compare the outcomes of acute ischemic stroke (AIS) patients with low admission NIHSS score who underwent mechanical thrombectomy versus those treated with IV tPA alone.

 

Stroke-related disability is relatively common even in patients with mild stroke. Per American Stroke Association guidelines, there is Level IIb evidence supporting endovascular management of patients with large vessel occlusion (LVO) in ICA or proximal M1 and NIHSS < 6. 

 

We performed a retrospective chart review from January 2013 to June 2017 of all patients with confirmed AIS, NIHSS ≤ 6, and 3-month follow-up modified Rankin Scale (mRS) who underwent mechanical thrombectomy (with or without IV tPA) or received IV tPA alone.  We used Fisher’s exact test to compare outcomes (favorable: mRS 0-2, unfavorable: mRS 3-6) between patients who underwent thrombectomy and those who did not.

 

We identified 56 patients with NIHSS ≤ 6.  Of the 42 patients with 3-month follow-up mRS scores, 17 (40.5%) had no change in mRS from preadmission to 3-month follow-up.  Unfavorable outcomes (mRS 3-6 at follow-up) occurred in 4 of 5 patients (80%) who underwent mechanical thrombectomy compared to 9 of 37 patients (24.3%) who received IV tPA alone (Fisher’s exact p-value = 0.0259). Fifteen of the 42 patients had LVO and, among these patients, there was no significant difference in follow-up mRS scores between those that underwent thrombectomy and those that did not (Fisher’s exact p-value = 0.5804).

 

In our study, patients with AIS and admission NIHSS < 6 who received IV tPA alone had better 3-month outcomes than those who received mechanical thrombectomy.  Among patients with low NIHSS and LVO, there was no significant difference in outcome between who those who underwent thrombectomy versus those who did not.  Larger studies with CT or MR perfusion are required for validation.

 

Authors/Disclosures
Roohi Katyal, MD (Louisiana State University Health Sciences Center)
PRESENTER
Dr. Katyal has nothing to disclose.
Claire E. Delpirou Nouh, MD (University of Oklahoma Health Science Center, Department of Neurology) The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities.
Chao Xu Chao Xu has nothing to disclose.
No disclosure on file
David L. Gordon, MD, FAHA, FANA, FAAN (University of Oklahoma HSC) Dr. Gordon has nothing to disclose.